“…Virtual environments can be entirely customized, allowing providers to work with patients with difficulty imagining feared memories (Riva, 2005; Rizzo et al, 2012a); VR HMDs are increasingly portable and can be used in private offices (Birckhead et al, 2019; Riva, 2005; Rothbaum and Hodges, 1999); and providers can have unparalleled control over their patient’s sensory intensity and details that would be otherwise impossible for imaginal or in situ treatments (Finseth et al, 2018; Maples-Keller et al, 2017; Rizzo et al, 2012b: 231). Biometric data sensors paired with VR setups also allow providers to collect and measure patients’ real-time psychophysiological responses to stress, such as heart rate and perspiration (Buckwalter, 2015; Rizzo et al, 2012b). Today VR exposure as a therapeutic assessment and treatment modality has expanded to a wide range of medical, surgical, psychiatric, and neurocognitive conditions (Birckhead et al, 2019), including pain control, phobias and anxiety disorders (Botella et al, 2015; Valmaggia et al, 2016), and addiction (Girard et al, 2009).…”